Tonix names CEO's son George Lederman EVP to lead AI and deals

Image
Tonix names CEO's son George Lederman EVP to lead AI and deals

BERKELEY HEIGHTS -- November 19, 2026 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) appointed George Lederman, Ph.D., as Executive Vice President, Strategy and Transformation, effective October 30, 2026. He is the son of Seth Lederman, M.D., Tonix's President, CEO and Chairman. The company announced the hire on November 2, three days after the start date.

Lederman takes charge of AI, cost management and business development

George Lederman will lead AI initiatives across the organization, with the stated aim of improving operational efficiency and managing costs. He will also run business development, including evaluating partnerships and licensing deals meant to advance clinical programs and share development costs.

Chief Technical Officer Siobhan Fogarty says Tonix intends to evaluate partnership opportunities for select pipeline programs with the goal of sharing development costs. Lederman himself points to Lyme disease prevention and immunology as areas of untapped potential.

The release names five development programs or indications:

  • TNX-102 SL in major depressive disorder, in Phase 2 studies
  • TNX-102 SL in acute stress disorder/acute stress reaction, in Phase 2 studies
  • TNX-4800, an anti-OspA antibody for Lyme disease prevention, Phase 2-ready
  • TNX-1500, an anti-CD40L antibody for preventing kidney transplant rejection, Phase 2-ready
  • TNX-801, a horsepox-based vaccine for mpox and smallpox, in development

On the commercial side, Tonix markets TONMYA for fibromyalgia in adults, plus the migraine products Zembrace SymTouch and Tosymra. The company describes TONMYA as the first fibromyalgia medicine approved in more than 15 years.

Aliaxis record shows 10 transactions in four years

Lederman joins from Aliaxis, where he was Vice President, Global Strategy, reporting to the CEO. Over his four-year tenure the group divested six assets and acquired four companies. That is 10 transactions, or about 2.5 a year by our calculation, and a net two fewer assets.

The release says he supported business unit restructurings at Aliaxis, including a 10% enterprise-wide fixed cost reduction. It credits him with supporting, not leading, those efforts.

Before Aliaxis he was an Associate Partner at McKinsey & Company, where he helped build the firm's digitization practice. He holds a Ph.D. in Advanced Infrastructure Systems from Carnegie Mellon University, two Carnegie Mellon master's degrees and a Princeton bachelor's degree in Civil Engineering.

Independent directors approved the related-party hire and his pay

Tonix says independent members of its Board and Audit Committee reviewed and approved the appointment under its related party transactions policy. Independent Board members and the Compensation Committee approved his compensation. The company did not disclose the compensation terms or any cost-savings target for the AI program.

The release's risk-factor list includes the company's need for additional financing. It refers investors to the Form 10-K for the year ended December 31, 2025, filed with the SEC on March 12, 2026.

Published by:
fairsonline_team
Products
Target market(s)
News Type